1. GPCR/G Protein Neuronal Signaling Membrane Transporter/Ion Channel Immunology/Inflammation NF-κB Metabolic Enzyme/Protease
  2. Adrenergic Receptor Calcium Channel Potassium Channel Reactive Oxygen Species (ROS)
  3. Landiolol

Landiolol (ONO1101) 是一种高选择性的超短效 β1 肾上腺素受体竞争性抑制剂。Landiolol 特异性阻断心脏 β1 受体,降低心率和心肌耗氧量。Landiolol 在脓毒症模型中抑制 TNF-α 诱导的线粒体过度氧消耗和活性氧 (ROS) 生成,减轻肾损伤。Landiolol 对心脏离子通道 (如 L 型钙电流、内向整流钾电流) 影响甚微,负性肌力作用较弱。Landiolol 可用于围手术期心动过速控制、脓毒症相关急性肾损伤的保护研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Landiolol Chemical Structure

Landiolol Chemical Structure

CAS No. : 133242-30-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Landiolol 的其他形式现货产品:

Customer Review

Other Forms of Landiolol:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Landiolol (ONO1101) is a highly selective, ultra-short-acting competitive inhibitor of β1 adrenergic receptors. Landiolol specifically blocks cardiac β1 receptors, reducing heart rate and myocardial oxygen consumption. Landiolol inhibits TNF-α-induced excessive mitochondrial oxygen consumption and reactive oxygen species production in a sepsis model, alleviating renal injury. Landiolol has little effect on cardiac ion channels (such as L-type calcium current and inward rectifier potassium current) and has a weak negative inotropic effect. Landiolol can be used for perioperative tachycardia control and protection studies of sepsis-related acute kidney injury[1][2][3].

IC50 & Target

Beta-1 adrenergic receptor

 

L-type calcium channel

 

IrK

 

体外研究
(In Vitro)

Landiolol (10 μM;24 h) 显著抑制 HEK293 细胞中 TNF-α (0.5 nM) 诱导的线粒体氧消耗率 (OCR) 升高,使基础 OCR 从 123% 降至 94.8%,并减少活性氧 (ROS) 生成[1]
Landiolol (10 μM;24 h) 抑制 TNF-α (0.5 nM) 诱导的 HEK293 细胞的过度糖酵解能力,但不显著影响其基础糖酵解 (ECAR) 水平[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: HEK293 cells
Concentration: 10 μM (Landiolol)
Incubation Time: 24 h; with 0.5 nM TNF-α
Result: Resulted in a significant reduction in basal OCR compared to TNF-α alone. The OCR, normalized to control (100%), decreased from 123.9%±16.6% (TNF-α only) to 94.8%±13.3% (TNF-α + Landiolol).
Attenuated maximal OCR and ATP production, indicating inhibition of mitochondrial hyperactivity.
Significantly lowered intracellular ROS levels, measured via dichlorodihydrofluorescein (DCF) assay.
体内研究
(In Vivo)

Landiolol (0.1 mg/kg/min;静脉输注;单剂量;6 h) 显著降低脂多糖 (LPS) 诱导大鼠急性肾损伤模型的血清肌酐和乳酸浓度,减轻肾小管坏死和炎症损伤。Landiolol 可能不通过全身抗炎或抗氧化作用介导肾脏保护作用[2]
Landiolol 对心脏功能的影响小于 Esmolol (HY-B1392A),不会直接缩短动作电位时程 (APD)[3]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: LPS-induced Acute Kidney Injury Rat Model (250-300 g,6-8 weeks old)[2]
Dosage: 0.1 mg/kg/min
Administration: Continuous intravenous infusion starting at the time of LPS administration (7.5 mg/kg, iv), maintained for 6 h
Result: Significantly improved renal function compared to the LPS group.
Decreased serum creatinine levels to 0.7 ± 0.3 mg/mL versus 1.4 ± 0.7 mg/mL in the LPS group, and decreased lactate levels to 3.8 ± 0.7 mmol/L versus 6.5 ± 1.3 mmol/L, at 6 h.
Reduced tubular degeneration, dilation, and acute necrosis in the renal cortex and medulla in the landiolol group compared to the LPS group.
Urinary 8-OHdG, a marker of oxidative stress, was increased in both groups but not significantly different between them, indicating landiolol’s renoprotection was not mediated by systemic anti-inflammatory or antioxidant effects.
Clinical Trial
分子量

509.59

Formula

C25H39N3O8

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Landiolol
目录号:
HY-100607
需求量: